METABOLIC / SINGLE
5-AMINO-1MG
5MG · 50MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
An NNMT (nicotinamide N-methyltransferase) inhibitor studied in metabolic and fat-oxidation research. Note: the source material spells this compound '5-Amino-1MQ'; DXBTides' catalogue lists it as '5-AMINO-1MG' — see the naming note below.
Available Strengths
- 5MG (5AM)
- 50MG (50AM)
Research Protocol
Reference tolerance-then-standard schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Days 1–2 (tolerance) | 2.5 mg | 20 | 0.2 mL |
| Days 3+ (standard) | 5 mg | 40 | 0.4 mL |
Reconstitution
≈12.5 mg/mL once reconstituted
- Draw 4.0 mL of bacteriostatic water per 50 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Reported to selectively inhibit NNMT, potentially sparing nicotinamide for NAD+ synthesis and activating metabolic pathways associated with fat oxidation and mitochondrial function.
Storage
−20°C, stable up to 24 months. 2–8°C, use within 2–4 weeks.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
- The cited source spells this compound '5-Amino-1MQ'; DXBTides' catalogue name '5-AMINO-1MG' has not been changed as part of this content addition — flagged separately for supplier-label verification.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source